Colgate-palmolive (CL) Stock
Global oral care and household products leader. Here's the price, business snapshot, and what's worth knowing about Colgate-palmolive in July 2026.
Colgate‑Palmolive Co. (CL) is a global consumer‑goods company best known for oral‑care brands such as Colgate, alongside personal‑care and household products. With a market capitalisation around US$63.5bn, it generates steady, largely predictable cash flows from everyday consumables sold across retail, pharmacy and e‑commerce channels. Investors often note Colgate’s brand strength, broad distribution network and dividend track record as attractions for income‑orientated portfolios. Growth drivers include premiumisation of oral care, expansion in emerging markets and rising e‑commerce penetration. Key risks are margin pressure from commodity and freight costs, currency volatility in international markets, intense competition from other large consumer goods firms and private labels, and changing consumer preferences. Colgate is generally viewed as a defensive, lower‑volatility stock but like all equities its value can fall as well as rise. This summary is educational only and not personal investment advice — suitability depends on an investor’s goals, risk tolerance and timeframe.
Why It’s Moving
Colgate-Palmolive is under pressure as valuation worries outweigh its steady growth story.
- Analysts are flagging Colgate-Palmolive as expensive after a long rally, arguing the stock’s valuation now leaves less room for upside and more room for disappointment.
- The bearish case centers on growth that has been driven more by price increases than by higher product volume, which raises questions about how durable the company’s momentum really is.
- Margin gains may be nearing a peak, and in a higher-rate market, the stock’s low dividend yield looks less compelling versus its valuation, adding to downside risk concerns.
Colgate-Palmolive is under pressure as valuation worries outweigh its steady growth story.
- Analysts are flagging Colgate-Palmolive as expensive after a long rally, arguing the stock’s valuation now leaves less room for upside and more room for disappointment.
- The bearish case centers on growth that has been driven more by price increases than by higher product volume, which raises questions about how durable the company’s momentum really is.
- Margin gains may be nearing a peak, and in a higher-rate market, the stock’s low dividend yield looks less compelling versus its valuation, adding to downside risk concerns.
When is the next earnings date for COLGATE-PALMOLIVE CO (CL)?
Colgate-Palmolive (CL) is expected to report next on July 31, 2026, with some sources listing August 7, 2026 as an alternative estimate. The upcoming release should cover Q2 2026 results. The most commonly cited schedule points to a late-July announcement before the market opens.
Stock Performance Snapshot
Analyst Rating
Analysts recommend buying Colgate-Palmolive's stock, expecting its price to rise in the future.
Financial Health
Colgate-Palmolive is successfully generating strong revenue and cash flow, with healthy profit margins.
Dividend
Colgate-Palmolive's dividend yield of 2.25% is decent, providing steady returns for investors. If you invested $1000 you would be paid $22.50 a year in dividends (based on the last 12 months).
View more stocks by downloading the app for FREE
It only takes 60 seconds.
Discover More Opportunities
ESTEE LAUDER COMPANIES INC
Estee Lauder manufactures and markets personal care, fragrance, and cosmetics products worldwide
CHURCH & DWIGHT
Manufacturer of household and personal care products
CLOROX CO
The Clorox Company produces a variety of household products, including cleaning, food, and personal care products.
Baskets Featuring CL
Unilever Food Spin-Off and McCormick Deal Explained
Unilever is spinning off its food division to merge with McCormick, creating a $20 billion revenue powerhouse in the consumer flavor market. This historic transaction creates ripple effects across the consumer staples sector, spotlighting potential buyout targets in packaged foods and shifting dynamics in personal care.
Published: 1 April 2026
Explore BasketJ&J Talc Crisis Impact Explained | Health Stocks
A jury verdict found Johnson & Johnson liable in a talc cancer case, one of over 63,000 similar lawsuits the company faces. This ongoing legal crisis may drive consumers toward competitors, creating an investment opportunity in other personal care and consumer health companies.
Published: 15 February 2026
Explore BasketConsumer Spending Shifts: Which Stocks May Benefit?
A significant drop in consumer confidence to a 12-year low signals potential economic headwinds and a shift in spending habits. This creates an investment opportunity in consumer staples and discount retailers, which often outperform as households prioritize essential purchases.
Published: 28 January 2026
Explore BasketFlight to Safety Assets | Fed Uncertainty Overview
A landmark Supreme Court case is set to determine whether the president can fire a Federal Reserve governor, placing the central bank's political independence at a critical juncture. This event could spur market volatility, potentially benefiting safe-haven assets and defensive stocks that investors turn to in times of uncertainty.
Published: 21 January 2026
Explore BasketResilient Consumer Stocks | Labor Market Strength
The unexpected drop in U.S. jobless claims highlights the continued strength of the labor market. This sustained employment suggests robust consumer spending power, creating an investment opportunity in companies poised to benefit from confident consumers.
Published: 17 January 2026
Explore BasketPersonal Care Stocks | Talc Lawsuit Impact on Market
A jury has ordered Johnson & Johnson to pay $40 million in a lawsuit linking its talc-based powder to ovarian cancer, adding to its significant legal challenges. This ongoing litigation creates an opportunity for competitors offering safer, talc-free personal care alternatives to gain market share.
Published: 13 December 2025
Explore BasketBrazil Consumer Market (Multinational Corporations)
Brazil's consumer sector shows persistent growth, offering a familiar area of the economy for Brazilians to watch. This basket provides exposure to this trend through the global multinational corporations that produce, package, and sell everyday goods across Brazil.
Published: 23 October 2025
Explore BasketUS Conglomerates: Could They Diversify Your Portfolio?
Brazilian investors may find opportunities to reduce portfolio volatility tied to the domestic economy through time-tested, multi-sector business models. This basket provides exposure to a selection of large-cap, US-listed conglomerates with diversified global operations.
Published: 20 October 2025
Explore BasketLuxury Beauty M&A: What's Next After Kering Deal?
Kering's potential $4 billion sale of its beauty unit to L'Oréal signals a major consolidation in the luxury cosmetics industry. This theme focuses on other beauty and personal care companies that could benefit from the ripple effects of this large-scale acquisition and market shift.
Published: 19 October 2025
Explore BasketWhy You’ll Want to Watch This Stock
Steady income potential
Long history of dividends and predictable cash flow may interest income investors, though yields and payouts can change with business conditions.
Emerging market growth
Expansion in Asia and Latin America can drive volume and value growth, but results can be affected by currency swings and local competition.
Innovation and channels
New product premiumisation and e‑commerce penetration could boost margins and reach, yet fierce competition and execution risk remain.
Compare Colgate-Palmolive with other stocks
3M vs Colgate-Palmolive
3M vs Colgate-Palmolive
Mondelez vs Colgate-Palmolive
Mondelez vs Colgate-Palmolive
Illinois Tool Works vs Colgate-Palmolive
Illinois Tool Works vs Colgate-Palmolive
Why invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
